期刊文献+

Transcriptomic landscapes underlying response and resistance to HDAC inhibitor chidamide in triple-negative breast cancer

原文传递
导出
摘要 Triple-negative breast cancer(TNBC)remains a medical challenge due to limited therapeutics.1 Histone deacetylases(HDACs)play vital roles in chromatin remodeling and epigenetics,and their dysregulation is implicated in malignancies,including TNBC.
出处 《Genes & Diseases》 2026年第1期72-75,共4页 基因与疾病(英文)
基金 supported by the GuangDong Basic and Applied Basic Research Foundation(China)(No.2021A1515111225 to Yanxia Zhang 2024A1515013172 to Linhai Li 2023A1515030061 to Bin Xiao) the Science and Technology Program of Qingyuan,Guangdong,China(No.2022KJJH027 to Linhai Li).

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部